Austin Startup Haemanthus Faces Scrutiny Over Leadership
The diagnostic firm is under the spotlight due to CEO Billy Evans' personal connection to Elizabeth Holmes.
Updated on Oct. 26, 2026 in Startups
Live Poll
Should individuals convicted of corporate fraud be trusted if they launch new businesses after prison?
Concerns have surfaced regarding the Austin diagnostic startup Haemanthus and its CEO, Billy Evans, due to his connection to Elizabeth Holmes. Former Theranos employee Erika Cheung raised the issue, citing Holmes' history of investor fraud and allegations that she has continued to advise Evans from prison.
Why it matters
The intersection of Austin's burgeoning health-tech startup scene and the lingering fallout from the Theranos case has brought fresh scrutiny to local operations. Residents and investors are grappling with questions about corporate accountability and leadership integrity within the city's tech corridor.
Elizabeth Holmes is serving a sentence recently adjusted to 10 years and 3 months, with her scheduled move to an Austin halfway house arriving in 2027. The extent of any professional influence remains unverified beyond the company's public denial of her involvement.
The players
Billy Evans
The CEO of the Austin-based diagnostic startup Haemanthus and partner of Elizabeth Holmes.
Erika Cheung
A former employee at Theranos who has publicly voiced concerns regarding Elizabeth Holmes.
Elizabeth Holmes
The former Theranos founder convicted in 2022 of defrauding investors.
Haemanthus
An Austin-based diagnostic startup company led by CEO Billy Evans.
The details
Billy Evans, the partner of Elizabeth Holmes, serves as CEO of the Austin-based diagnostic startup Haemanthus. Following May 2025 reports suggesting Holmes had been advising Evans from prison, Erika Cheung expressed concern, arguing that Holmes has not demonstrated accountability. Haemanthus has publicly stated on X that Holmes maintains zero involvement in the firm.
Timeline
2022: Elizabeth Holmes was convicted of defrauding investors.
May 2025: Reports emerged that Holmes was advising Evans from prison.
August 23, 2027: Holmes is scheduled to move to an Austin halfway house.
February 22, 2030: Holmes is scheduled for release from prison.
The Texas Context
The situation reflects the ongoing professional scrutiny following the 2022 Elizabeth Holmes conviction for investor fraud. It serves as a stark reminder of how local tech reputations are navigated in the wake of high-profile industry failures.
Local investors and tech professionals may monitor further disclosures from the company regarding its leadership structure. Public attention will likely increase as the 2027 date for Holmes' transition to a local halfway house approaches.
The takeaway
Transparency remains the primary metric for residents to watch when evaluating new health-tech ventures in the city. Observers should continue to track company disclosures and verify leadership roles to ensure clarity in the diagnostic market.
Further reading
For more on the local tech ecosystem, visit Startups.
Source note: This article includes information reported by NewsNation.
Live Poll
Should individuals convicted of corporate fraud be trusted if they launch new businesses after prison?
